what if you take too much semaglutide Can overdose on Ozempic? Ozempic and GLP-1 Drugs: Risk

By distribution channel, the retail pharmacies segment held the largest market share in 2025

Some patients, termed super-responders, lose more weight than expected

This review paper highlights preclinical and clinical studies indicating that GLP-1 drugs, including low dose formulations such as exenatide, may offer neuroprotective benefits by targeting hallmarks of brain aging through enhancing DNA repair, boosting antioxidant responses, reducing inflammation and improving mitochondrial function

Weight loss injections, particularly GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro), have transformed obesity treatment in the United States

Still, GLP-3 does not describe a correct drug class

All adults had a recorded diagnosis of obesity defined as BMI of 30 kg/m 2 or higher or BMI of 27 kg/m 2 to 29.9 kg/m 2 with at least one weight-related comorbidity